ARQ-252 cream 0.3%

DRUG2 trials

Sponsors

Arcutis Biotherapeutics, Inc.

Conditions

Chronic Hand EczemaVitiligo

Phase 1

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

CompletedNCT04378569

Arcutis Biotherapeutics, Inc.Chronic Hand Eczema

Start: 2020-04-20End: 2021-02-24Updated: 2024-04-05

Phase 2

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

TerminatedNCT04811131

Arcutis Biotherapeutics, Inc.Vitiligo

Start: 2021-03-04End: 2021-08-09Updated: 2024-07-12